An Overview of National Alcohol Screening Day: Trends From 2001 to 2003

por Dupre, Matthew E., Aseltine, Robert H., Wallenstein, Gene V., Jacobs, Douglas G.
Publicado 2004

Tofacitinib in Combination With Conventional Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient‐Reported Outcomes From a Phase III Randomiz...

por Strand, Vibeke, Kremer, Joel M., Gruben, David, Krishnaswami, Sriram, Zwillich, Samuel H., Wallenstein, Gene V.
Publicado 2017

Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials

por Rendas-Baum, Regina, Kosinski, Mark, Singh, Amitabh, Mebus, Charles A., Wilkinson, Bethany E., Wallenstein, Gene V.
Publicado 2017

Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors

por Rendas-Baum, Regina, Wallenstein, Gene V, Koncz, Tamas, Kosinski, Mark, Yang, Min, Bradley, John, Zwillich, Samuel H
Publicado 2011

Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis

por Jansen, Jeroen P., Vieira, Maria-Cecilia, Bradley, John D., Cappelleri, Joseph C., Zwillich, Samuel H., Wallenstein, Gene V.
Publicado 2016

Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

por Strand, Vibeke, Mysler, Eduardo, Moots, Robert J, Wallenstein, Gene V, DeMasi, Ryan, Gruben, David, Soma, Koshika, Iikuni, Noriko, Smolen, Josef S, Fleischmann, Roy
Publicado 2019